Clinical Use of DPP-4 Inhibitors
Author:
Publisher
Frontiers Media SA
Subject
Endocrinology, Diabetes and Metabolism
Reference86 articles.
1. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus;Gerich;Mayo Clin Proc,2003
2. The incretin concept today;Creutzfeldt;Diabetologia,1979
3. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations;Nauck;J Clin Endocrinol Metab,1993
4. Incretin hormones: their role in health and disease;Nauck;Diabetes Obes Metab,2018
5. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes;Nauck;Diabetologia,1986
Cited by 195 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring Triazole Derivatives as DPP IV Inhibitors: Advancing Type II Diabetes Treatment via Molecular Structure Investigation and Pharmacophore Modelling;Chemistry Africa;2024-01-19
2. Oral Glucose‐Lowering Agents;Textbook of Diabetes;2024-01-12
3. Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals;Metabolic Syndrome and Related Disorders;2024-01-03
4. The entero-insular axis and metabolic syndrome;Metabolic Syndrome;2024
5. Glucagon and the metabolic syndrome;Metabolic Syndrome;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3